ImStem, UConn Obtain U.S. Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases
The U.S. Patent and Trademark Office has issued a patent for human embryonic stem cell derived mesenchymal stem cells, called hES-T-MSC or T-MSC, and for their method of production.